サマリー

Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for Non-Opioid has increased significantly.

Market Analysis and Insights: Global Non-Opioid Pain Treatment Market
The global Non-Opioid Pain Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Opioid Pain Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Opioid Pain Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Opioid Pain Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Opioid Pain Treatment market.

Global Non-Opioid Pain Treatment Scope and Market Size
Non-Opioid Pain Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Opioid Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins

Segment by Application
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2016-2027)
2.2 Non-Opioid Pain Treatment Growth Trends by Regions
2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-Opioid Pain Treatment Industry Dynamic
2.3.1 Non-Opioid Pain Treatment Market Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2020
3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.7 Date of Enter into Non-Opioid Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027)

5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2016-2027)
6.2 North America Non-Opioid Pain Treatment Market Size by Type
6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
6.3 North America Non-Opioid Pain Treatment Market Size by Application
6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
6.4 North America Non-Opioid Pain Treatment Market Size by Country
6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2016-2027)
7.2 Europe Non-Opioid Pain Treatment Market Size by Type
7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2027)
7.3 Europe Non-Opioid Pain Treatment Market Size by Application
7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2027)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country
7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2016-2027)
9.2 Latin America Non-Opioid Pain Treatment Market Size by Type
9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-Opioid Pain Treatment Market Size by Application
9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country
9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Details
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.1.5 Allergan PLC Recent Development
11.2 Canopy Growth
11.2.1 Canopy Growth Company Details
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.2.5 Canopy Growth Recent Development
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Details
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.3.5 Medical Marijuana Inc. Recent Development
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Details
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.4.5 Panag Pharma Inc. Recent Development
11.5 Tilray
11.5.1 Tilray Company Details
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.5.5 Tilray Recent Development
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Details
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.6.5 Aphria Inc. Recent Development
11.7 Bedrocan
11.7.1 Bedrocan Company Details
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.7.5 Bedrocan Recent Development
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Details
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.8.5 Cara Therapeutics Recent Development
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Details
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.9.5 Centrexion Therapeutics Recent Development
11.10 CHT Medical
11.10.1 CHT Medical Company Details
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.10.5 CHT Medical Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.11.5 Cronos Group Recent Development
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Details
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.12.5 GW Pharmaceuticals Recent Development
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Details
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.13.5 Medropharm Gmbh Recent Development
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Details
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.14.5 US Worldmeds LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details